Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 734.7 INR 0.19% Market Closed
Market Cap: 4.2T INR

SUNPHARMA's latest stock split occurred on Jul 29, 2013

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, SUNPHARMA traded at 1117.3 per share. Afterward, the share price was about 526.2529.

The adjusted shares began trading on Jul 29, 2013. This was SUNPHARMA's 6th stock split, following the previous one in Nov 25, 2010.

Last Splits:
Jul 29, 2013
2-for-1
Nov 25, 2010
5-for-1
May 27, 2004
2-for-1
Jan 13, 2003
2-for-1
Mar 8, 2000
3-for-1
Pre-Split Price
516.4536 1 117.3
Post-Split Price
526.2529
Before
After
Last Splits:
Jul 29, 2013
2-for-1
Nov 25, 2010
5-for-1
May 27, 2004
2-for-1
Jan 13, 2003
2-for-1
Mar 8, 2000
3-for-1

Sun Pharmaceutical Industries Ltd
Stock Splits History

SUNPHARMA Stock Splits Timeline
Jul 29, 2013
Jul 29, 2013
Split 2-for-1
x2
Pre-Split Price
516.4536 1 117.3
Post-Split Price
526.2529
Before
After
Nov 25, 2010
Nov 25, 2010
Split 5-for-1
x5
Pre-Split Price
207.4139 2 273.4
Post-Split Price
207.1037
Before
After
May 27, 2004
May 27, 2004
Split 2-for-1
x2
Pre-Split Price
30.6382 708.6
Post-Split Price
32.0045
Before
After
Jan 13, 2003
Jan 13, 2003
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
23.6942
Before
After
Mar 8, 2000
Mar 8, 2000
Split 3-for-1
x3
Pre-Split Price
N/A
Post-Split Price
23.6942
Before
After
Mar 6, 2000
Mar 6, 2000
Split 3-for-1
x3
Pre-Split Price
N/A
Post-Split Price
23.6942
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Mar 28, 2025
Yellow Hat Ltd
OTC:YLLWF
2-for-1
x2
16.93 8.465 USD 8.465 8.2404 USD
Mar 25, 2025
CMC Metals Ltd
XTSX:CMB
1-for-10
/10
0.02 0.2 CAD 0.25 0.25 CAD
Mar 25, 2025
Rent.com.au Ltd
ASX:RNT
63-for-62
x1.0161290322581
0.021 0.0207 AUD 0.018 0.018 AUD
Mar 25, 2025
U
US Critical Metals Corp
OTC:USCMF
1-for-2
/2
0.06 0.15 USD 0.1127 0.1127 USD
Mar 25, 2025
CMC Metals Ltd
F:ZM5P
1-for-10
/10
0.0038 0.038 EUR 0.009 0.009 EUR
Load More

Sun Pharmaceutical Industries Ltd
Glance View

Economic Moat
Narrow
Market Cap
4.2T INR
Industry
Pharmaceuticals

Sun Pharmaceutical Industries Ltd. began its journey in 1983 with a vision to provide quality healthcare to billions worldwide. Originating from India, Sun Pharma has steadily emerged as a global leader in the pharmaceutical industry. The company’s strength stems from its ability to efficiently manufacture, develop, and market a wide range of generic pharmaceuticals and therapeutic formulations. With a significant footprint in over 100 countries, it is driven by a robust pipeline of drugs encompassing key therapeutic areas such as psychiatry, cardiology, neurology, and gastroenterology. A hallmark of Sun Pharma’s strategy has been its strong focus on research and development, specifically in creating affordable medicines that tackle complex medical conditions. The company’s business model revolves around a dual strategy: the development of complex generics and innovative specialty products. This approach allows Sun Pharma to capitalize on both the high-volume, cost-efficient production of off-patent drugs and the value-driven, specialized therapy segments. By leveraging its R&D capabilities, the company explores new drug delivery systems and complex formulations, which not only ensure a steady flow of new product introductions but also enhance its competitive edge in the market. This blend of innovation and scale positions Sun Pharmaceutical Industries Ltd. as a dynamic force in the global pharmaceutical landscape, continually navigating the intricate balance of providing both profitable growth and accessible healthcare solutions.

SUNPHARMA Intrinsic Value
1 082.77 INR
Overvaluation 38%
Intrinsic Value
Price
Back to Top